Trials / Completed
CompletedNCT02168426
Randomized Control Trial on Seprafilm and Guardix in Preventing Ileus
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- All
- Age
- 25 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the efficacy of Seprafilm and guardix in reducing the incidence of bowel obstruction and to evaluate the incidence of all serious adverse events (SAEs) associated with the use of Seprafilm and guardix occurring within 30 days postoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Guardix | Applying 6g of guardix during abdominal surgery |
| PROCEDURE | Seprafilm | Applying 1 sheet of seprafilm during abdominal surgery |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-12-01
- Completion
- 2015-02-01
- First posted
- 2014-06-20
- Last updated
- 2015-09-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02168426. Inclusion in this directory is not an endorsement.